SCHEMBL181472

SCHEMBL181472

CCOc1ccc(OC(C)=O)c(CC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
AKT1 P31749 1/20 0.47
LMNA P02545 4/20 0.46
EPHX1 P07099 1/20 0.46
NPC1 O15118 1/20 0.46
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 2/20 0.44
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
CYP1A2 P05177 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PARP10 Q53GL7 1/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12166002 0.83 KDM4E (0.51) KDM4ELMNAEPHX1NPC1PKM
SCHEMBL326803 0.82 NQO1 (0.52) KDM4EEPHX1HTTALDH1A1MTNR1A
SCHEMBL9150083 0.81 KDM4E (0.56) KDM4ELMNAEPHX1NPC1PKM
SCHEMBL1317147 0.81 CFD (0.61) KDM4ELMNAEPHX1RAB9AALDH1A1
SCHEMBL14264240 0.81 HSD17B10 (0.50) KDM4EAKT1ALDH1A1MTNR1AMTNR1B
SCHEMBL3234922 0.80 NQO1 (0.61) LMNANPC1PKMALDH1A1KMT2A
SCHEMBL15780081 0.80 AKT1 (0.50) KDM4EAKT1LMNANPC1PKM
SCHEMBL7029122 0.80 KDM4E (0.48) KDM4ELMNAEPHX1NPC1PKM
SCHEMBL6615190 0.79 KDM4E (0.54) KDM4ELMNAEPHX1NPC1PKM
SCHEMBL28898703 0.78 KDM4E (0.51) KDM4EAKT1LMNANPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334687-B1 DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES PFIZER (US) 2012-01-04 EP disclosed
EP-2334687-A1 DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES Pfizer Inc. (US) 2011-06-22 EP disclosed